Evidence map›Paper›PMID 42739626›Full record

ArticleJournal of clinical medicine2026

Initial Clinical Experience with Percutaneous Endocardial Septal Pulsed Field Ablation in Hypertrophic Obstructive Cardiomyopathy: A First-in-Human Case Series.

Haoruo Zhang, Yanfeng Tian, Songqing Yang, Rui Cao, Haoran Jing, Chunlin Gong, Jiaoyue Zhong, Yuran Chen, Siting Hong, Zhaojun Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Haoruo ZhangDepartment of Cardiology, First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Yanfeng TianDepartment of Cardiology, First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Songqing YangDepartment of Cardiology, First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Rui CaoDepartment of Cardiology, First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Haoran JingDepartment of Cardiology, First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Chunlin GongDepartment of Cardiology, First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Jiaoyue ZhongDepartment of Cardiology, First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Yuran ChenDepartment of Cardiology, First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Siting HongDepartment of Cardiology, First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Zhaojun WangDepartment of Cardiology, First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.ORCID 0009-0002-6596-7960

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

catheter ablationhypertrophic obstructive cardiomyopathyleft ventricular outflow tract obstructionpulsed field ablationseptal reduction therapy

Identifiers

PMID42739626
PMCPMC13566865

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.